SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-006835
Filing Date
2024-01-25
Accepted
2024-01-25 20:39:12
Documents
2
Period of Report
2024-01-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244073-7_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm244073-7_3seq1.xml 3 9426
2 EXHIBIT 24.1 tm244073d7_ex24-1.htm EX-24.1 8207
  Complete submission text file 0001104659-24-006835.txt   19117
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Issuer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 18 CAMPUS BOULEVARD SUITE 100 NEWTOWN SQUARE PA 19073
Business Address
Lutzker Stuart (Reporting) CIK: 0002009257 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41929 | Film No.: 24563845